VTRS Viatris
$19.63 -1.26%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-1.26%
YTD
+57.70%
P/E
—
P/B
0.97
ROE
-4.2%
Div yield
5.1%
Beta
0.62
Market cap
$22.0B
RSI (14)
52
Next earnings
Feb 24, 2027
Same sector · Health Care
Compare VTRS with NVO and JNJ →Follow VTRS in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$19.91
Close
$19.63
Day high
$20.10
Day low
$19.43
Volume
9.3M
Latest headlines
All You Need to Know About Viatris (VTRS) Rating Upgrade to Strong Buy
Yahoo Finance · Nov 20
Rising Sector Tide and Internal Milestones Fuel Viatris’ (VTRS) Gains
Yahoo Finance · Nov 20
Viatris Completes Acquisition of Pacira BioSciences
Yahoo Finance · Nov 17
Are Investors Undervaluing Viatris (VTRS) Right Now?
Yahoo Finance · Nov 17
CADILLAC FORMULA 1® TEAM WELCOMES VIATRIS AS OFFICIAL GLOBAL PHARMACEUTICAL PARTNER
Yahoo Finance · Nov 16
Viatris to Participate in Upcoming Investor Conferences
Yahoo Finance · Nov 11
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Nov 17, 2026 View → 10-Q Nov 5, 2026 View → 8-K Nov 5, 2026 View → 8-K Oct 8, 2026 View → 10-Q Aug 6, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell VTRS. Try it in the Lab to size a position and see the risk.